APA (7th ed.) Citation

Givi, T., Mohajerani, F., Tehrankhah, Z. M., Karimi Taheri, M., Amirahmadi, M., Babashah, S., & Sadeghizadeh, M. (2025). Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation. PLoS ONE, 20(12), 1. https://doi.org/10.1371/journal.pone.0335165

Chicago Style (17th ed.) Citation

Givi, Taraneh, Fatemeh Mohajerani, Zahra Moazezi Tehrankhah, Mohammadjavad Karimi Taheri, Maryam Amirahmadi, Sadegh Babashah, and Majid Sadeghizadeh. "Nano-curcumin Enhances the Sensitivity of Tamoxifen-resistant Breast Cancer Cells via the Cyclin D1-DILA1 Axis and the PI3K/AKT/mTOR Pathway Downregulation." PLoS ONE 20, no. 12 (2025): 1. https://doi.org/10.1371/journal.pone.0335165.

MLA (9th ed.) Citation

Givi, Taraneh, et al. "Nano-curcumin Enhances the Sensitivity of Tamoxifen-resistant Breast Cancer Cells via the Cyclin D1-DILA1 Axis and the PI3K/AKT/mTOR Pathway Downregulation." PLoS ONE, vol. 20, no. 12, 2025, p. 1, https://doi.org/10.1371/journal.pone.0335165.